NCT06168097

Brief Summary

OBJECTIVES :

  1. 1.To investigate the expression pattern of miRNAs operational in inflammation, angiogenesis, hypoxia, apoptosis and cell proliferation in eutopic and ectopic endometrium of patients with endometriosis and normal endometrium of healthy controls.
  2. 2.To understand the function of candidate predictive miRNAs for endometriosis by investigating their downstream targets and associated biological pathways.
  3. 3.Evaluation of significant outcome of objective 1 in serum samples to establish them as biomarkers.

Trial Health

75
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
200

participants targeted

Target at P75+ for not_applicable

Timeline
7mo left

Started Nov 2023

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
active not recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress82%
Nov 2023Dec 2026

First Submitted

Initial submission to the registry

October 21, 2023

Completed
25 days until next milestone

Study Start

First participant enrolled

November 15, 2023

Completed
28 days until next milestone

First Posted

Study publicly available on registry

December 13, 2023

Completed
3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 15, 2026

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 15, 2026

Last Updated

December 13, 2023

Status Verified

December 1, 2023

Enrollment Period

3.1 years

First QC Date

October 21, 2023

Last Update Submit

December 10, 2023

Conditions

Keywords

lining of uterusDiarrhea or constipation during a menstrual period.Heavy or irregular periods.Spotting or bleeding between menstrual periods.

Outcome Measures

Primary Outcomes (1)

  • 2. To understand the function of candidate predictive miRNAs for endometriosis by investigating their downstream targets and associated biological pathways

    ROC curve analysis is to estimate the sensitivity and specificity of miRNA expression levels to establish them as biomarkers for endometriosis.

    3 years

Secondary Outcomes (1)

  • To investigate the expression pattern of miRNAs and their downstream targets in endometrial tissues (samples of normal adult endometrium and ectopic and eutopic endometrium of patients with endometriosis)

    3 years

Study Arms (2)

100 women undergoing surgery (laparoscopy / laparotomy) with presumed diagnosis of endometriosis

EXPERIMENTAL

1. We Will take Both blood and tissue samples used to study them. 2. We Will take approximately 3 ml of blood which will be used from the blood sample collected for routine preoperative tests (Surgical profile) before their planned surgery. 3. Small tissue samples will be taken from the tissue which is surgically excised as a part of treatment. 4. It will include tissue from inner lining of uterus (endometrium) in all participants and from excised endometriosis tissue in patients with endometriosis.

Procedure: 100 women undergoing surgery (laparoscopy / laparotomy) with presumed diagnosis of endometriosisProcedure: women with intraoperative and / or histopathology findings suggestive of endometriosis

100 women undergoing surgery for gynaecological disorders other than endometriosis or adenomyosis

NO INTERVENTION

. We Will take Both blood and tissue samples used to study them. 2. We Will take approximately 3 ml of blood which will be used from the blood sample collected for routine preoperative tests (Surgical profile) before their planned surgery. 3.Small tissue samples will be taken from the tissue which is surgically excised as a part of treatment. 4\. It will include tissue from inner lining of uterus (endometrium) in all participants and from excised endometriosis tissue in patients with endometriosis.

Interventions

1. We Will take Both blood and tissue samples used to study them. 2. We Will take approximately 3 ml of blood which will be used from the blood sample collected for routine preoperative tests (Surgical profile) before their planned surgery. 3. Small tissue samples will be taken from the tissue which is surgically excised as a part of treatment. 4. It will include tissue from inner lining of uterus (endometrium) in all participants and from excised endometriosis tissue in patients with endometriosis.

100 women undergoing surgery (laparoscopy / laparotomy) with presumed diagnosis of endometriosis

1. We Will take Both blood and tissue samples used to study them. 2. We Will take approximately 3 ml of blood which will be used from the blood sample collected for routine preoperative tests (Surgical profile) before their planned surgery. 3. Small tissue samples will be taken from the tissue which is surgically excised as a part of treatment. 4. It will include tissue from inner lining of uterus (endometrium) in all participants and from excised endometriosis tissue in patients with endometriosis.

100 women undergoing surgery (laparoscopy / laparotomy) with presumed diagnosis of endometriosis

Eligibility Criteria

Age18 Years - 45 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Patients having more severe forms of endometriosis (Stage III and IV)
  • The probands were chosen randomly from the pool of available endometriosis patients and healthy controls of Indian origin.

You may not qualify if:

  • Diagnosis of non-endometriotic ovarian cysts, adenomyosis, ovarian cancer, fibroids, and stage I and II endometriosis.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Shraddha Ramchandani

Hyderabad, Telanagana, 500082, India

Location

MeSH Terms

Conditions

EndometriosisDiarrheaMenstruation DisturbancesMetrorrhagia

Interventions

LaparoscopyLaparotomy

Condition Hierarchy (Ancestors)

Genital Diseases, FemaleFemale Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesGenital DiseasesSigns and Symptoms, DigestiveSigns and SymptomsPathological Conditions, Signs and SymptomsPathologic ProcessesUterine HemorrhageUterine DiseasesHemorrhage

Intervention Hierarchy (Ancestors)

EndoscopyDiagnostic Techniques, SurgicalDiagnostic Techniques and ProceduresDiagnosisMinimally Invasive Surgical ProceduresSurgical Procedures, Operative

Study Officials

  • Shraddha Ramchandani

    Asian Institute of Gastroenterology

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
DIAGNOSTIC
Intervention Model
PARALLEL
Model Details: case control study 100 women undergoing surgery (laparoscopy / laparotomy) with presumed diagnosis of endometriosis and 100 women undergoing surgery for gynaecological disorders
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

October 21, 2023

First Posted

December 13, 2023

Study Start

November 15, 2023

Primary Completion (Estimated)

December 15, 2026

Study Completion (Estimated)

December 15, 2026

Last Updated

December 13, 2023

Record last verified: 2023-12

Data Sharing

IPD Sharing
Will not share

Locations